Tirzepatide linked to lower short-term endometrial cancer risk in large cohort study

A retrospective cohort study of more than 350,000 women with overweight or obesity found tirzepatide users had a lower hazard of newly recorded endometrial cancer diagnoses over…

By Maren Holt · Senior Reporter, GLP-1

Oct 28 04:18 ETSource: Bioengineer.org

From the source

Tirzepatide linked to lower short-term endometrial cancer risk in large cohort study
A retrospective cohort study of more than 350,000 women with overweight or obesity found tirzepatide users had a lower hazard of newly recorded endometrial cancer diagnoses over two years than women pursuing lifestyle modification.

Read at bioengineer.org

Source URL https://bioengineer.org/tirzepatide-linked-to-lower-short-term-endometrial-cancer-risk-in-large-cohort-study/